OCC

Ongoing Clinical Trials

Ongoing Clinical Trials of MagDI

Independent prospective evaluation continues through registered clinical trials. Below are currently registered studies of the MagDI System, with their stated objectives. Always consult ClinicalTrials.gov for the most current status, eligibility, and contact information.

Written by MagnaMetabolic Editorial Team Medically reviewed by Ariel Ortiz, MD — Bariatric & Metabolic Surgery Last reviewed: June 7, 2026
Active Registered Trial

MagDI Chile

ClinicalTrials.gov

  • Evaluates safety of the MagDI System.
  • Evaluates feasibility of magnetic duodeno-ileostomy.
  • Evaluates initial efficacy in adults with obesity, with or without Type 2 Diabetes.
View source
Active Registered Trial

MagDI Italy

ClinicalTrials.gov

  • Evaluates safety of the MagDI System.
  • Evaluates device performance.
  • Evaluates clinical outcomes in eligible patients.
View source

Participation in a clinical trial requires evaluation against study-specific eligibility criteria. Trial enrollment is not the same as receiving a clinically established treatment, and outcomes for individual participants are not guaranteed.

Evidence

Scientific References

Selected primary sources informing this page. External links open in a new tab; we do not control or endorse third-party content.

  1. ClinicalTrials.govMagDI Chile — A study to evaluate the safety, feasibility, and initial efficacy of the MagDI System in adults with obesity with or without Type 2 Diabetes.
  2. ClinicalTrials.govMagDI Italy — A study to evaluate the safety, performance, and clinical outcomes of the MagDI System.
Book Consultation